62
Views
1
CrossRef citations to date
0
Altmetric
Papers

Disturbance in cerebral spinal fluid sphingolipid content is associated with memory impairment in subjects infected with the human immunodeficiency virus

, , , &
Pages 445-456 | Received 16 Jul 2010, Accepted 08 Sep 2010, Published online: 18 Nov 2010

References

  • Aittoniemi J, Niemela PS, Hyvonen MT, Karttunen M, Vattulainen I (2007). Insight into the putative specific interactions between cholesterol, sphingomyelin, and palmitoyl-oleoyl phosphatidylcholine. Biophys J 92:1125–1137.
  • Albert SM, Flater SR, Clouse R, Todak G, Stern Y, Marder K (2003). Medication management skill in HIV: I. Evidence for adaptation of medication management strategies in people with cognitive impairment. II. Evidence for a pervasive lay model of medication efficacy. AIDS Behav 7:329–338.
  • Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799.
  • Bandaru VV, McArthur JC, Sacktor N, Cutler RG, Knapp EL, Mattson MP, Haughey NJ (2007). Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology 68:1481–1487.
  • Bandaru VV, Troncoso J, Wheeler D, Pletnikova O, Wang J, Conant K, Haughey NJ (2009). ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain. Neurobiol Aging 30:591–599.
  • Benton AL (1951). The Visual Retention Test. New York: Psychological Corporation.
  • Boisse L, Gill MJ, Power C (2008). HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol Clin 26:799–819, x.
  • Cardenas V, Meyerhoff D, Studholme C, Kornak J, Rothlind J, Lampiris H, Neuhaus J, Grant R, Chao L, Truran D, Weiner M (2009). Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J NeuroVirol 15:1–10.
  • Clement AB, Gamerdinger M, Tamboli IY, Lutjohann D, Walter J, Greeve I, Gimpl G, Behl C (2009). Adaptation of neuronal cells to chronic oxidative stress is associated with altered cholesterol and sphingolipid homeostasis and lysosomal function. J Neurochem 111:669–682.
  • Concha M, Selnes OA, McArthur J, Nance-Sproson T, Updike ML, Royal W, Solomon L, Vlahov D (1995). Normative data for a brief neuropsychological test battery in a cohort of injecting drug users. Int J Addict 30:832–841.
  • Cutler RG, Haughey NJ, Tammara A, McArthur JC, Nath A, Reid R, Vargas DL, Pardo CA, Mattson MP (2004a). Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia. Neurology 63:626–630.
  • Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004b). Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A 101:2070–2075.
  • Cutler RG, Pedersen WA, Camandola S, Rothstein JD, Mattson MP (2002). Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol 52:448–457.
  • Dunbar N, Brew B (1997). Neuropsychological dysfunction in HIV infection: a review. J NeuroAIDS 1:73–102.
  • Flowers KA, Robertson C (1985). The effects of Parkinson's disease on the ability to maintain a mental set. J Neurol Neurosurg Neuropsychiatry 48:517–529.
  • Gallegos CE, Pediconi MF, Barrantes FJ (2008). Ceramides modulate cell-surface acetylcholine receptor levels. Biochim Biophys Acta 1778:917–930.
  • Galvan C, Camoletto PG, Dotti CG, Aguzzi A, Ledesma MD (2005). Proper axonal distribution of PrP(C) depends on cholesterol-sphingomyelin-enriched membrane domains and is developmentally regulated in hippocampal neurons. Mol Cell Neurosci 30:304–315.
  • Gelman BB, Soukup VM, Holzer CE, 3rd, Fabian RH, Schuenke KW, Keherly MJ, Richey FJ, Lahart CJ (2005). Potential role for white matter lysosome expansion in HIV-associated dementia. J Acquir Immune Defic Syndr 39:422–425.
  • Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, Frank LR, Grant I (2009). White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J NeuroVirol 15:187–195.
  • Haughey NJ (2010). Sphingolipids in neurodegeneration. Neuromol Med Accessed: Aug 25 2010. [Epub ahead of print].
  • Haughey NJ, Cutler RG, Tamara A, McArthur JC, Vargas DL, Pardo CA, Turchan J, Nath A, Mattson MP (2004). Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann Neurol 55:257–267.
  • He X, Huang Y, Li B, Gong CX, Schuchman EH (2008). Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol Aging 31:398–408.
  • Huitema K, van den Dikkenberg J, Brouwers JF, Holthuis JC (2004). Identification of a family of animal sphingomyelin synthases. EMBO J 23:33–44.
  • Kaiser HJ, Lingwood D, Levental I, Sampaio JL, Kalvodova L, Rajendran L, Simons K (2009). Order of lipid phases in model and plasma membranes. Proc Natl Acad Sci U S A 106:16645–16650.
  • Klove H (1963). Clinical neuropsychology. Med Clin North Am 47:1647–1658.
  • Mao C, Obeid LM (2008). Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochim Biophys Acta 1781:424–434.
  • Marchesini N, Hannun YA (2004). Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem Cell Biol 82:27–44.
  • Marder K, Albert SM, McDermott MP, McArthur JC, Schifitto G, Selnes OA, Sacktor N, Stern Y, Palumbo D, Kieburtz K, Cohen B, Orme C, Epstein LG (2003). Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology 60:1467–1473.
  • McMurtray A, Nakamoto B, Shikuma C, Valcour V (2008). Cortical atrophy and white matter hyperintensities in HIV: the Hawaii Aging with HIV Cohort Study. J Stroke Cerebrovasc Dis 17:212–217.
  • Meer GV, Hoetzl S (2009). Sphingolipid topology and the dynamic organization and function of membrane proteins. FEBS Lett 584:1800–1805.
  • Miller EN, Satz P, Visscher B (1991). Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men. Neurology 41:1608–1616.
  • Mizutani Y, Kihara A, Igarashi Y (2006). LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with relatively broad substrate specificity. Biochem J 398:531–538.
  • Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J (2008). Evolution of HIV dementia with HIV infection. Int Rev Psychiatry 20:25–31.
  • Niemela PS, Hyvonen MT, Vattulainen I (2006). Influence of chain length and unsaturation on sphingomyelin bilayers. Biophys J 90:851–863.
  • Nygren H, Borner K, Hagenhoff B, Malmberg P, Mansson JE (2005). Localization of cholesterol, phosphocholine and galactosylceramide in rat cerebellar cortex with imaging TOF-SIMS equipped with a bismuth cluster ion source. Biochim Biophys Acta 1737:102–110.
  • Pewzner-Jung Y, Ben-Dor S, Futerman AH (2006). When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis. J Biol Chem 281:25001–25005.
  • Quinn PJ, Wolf C (2009). Thermotropic and structural evaluation of the interaction of natural sphingomyelins with cholesterol. Biochim Biophys Acta 1788:1877–1889.
  • Rey A (1941). L'examen psychological dans les cas d'encephalopathie traumatique. Arch Psychol 28:286–340.
  • Roc AC, Ances BM, Chawla S, Korczykowski M, Wolf RL, Kolson DL, Detre JA, Poptani H (2007). Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy. Arch Neurol 64:1249–1257.
  • Selnes OA, Jacobson L, Machado AM, Becker JT, Wesch J, Miller EN, Visscher B, McArthur JC (1991). Normative data for a brief neuropsychological screening battery. Multicenter AIDS Cohort Study. Percept Mot Skills 73:539–550.
  • Takeuchi J, Okada M, Toh-e A, Kikuchi Y (1995). The SMS1 gene encoding a serine-rich transmembrane protein suppresses the temperature sensitivity of the htr1 disruptant in Saccharomyces cerevisiae. Biochim Biophys Acta 1260:94–96.
  • Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P (2007). Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 45:174–182.
  • Valcour V, Watters MR, Williams AE, Sacktor N, McMurtray A, Shikuma C (2008). Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy. J NeuroVirol 14:362–367.
  • Wechsler D (1981). Wechsler Adult Intelligence Scale—Revised. New York:Psychological Corporation.
  • Wheeler D, Bandaru VV, Calabresi PA, Nath A, Haughey NJ (2008). A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain 131:3092–3102.
  • Wheeler D, Knapp E, Bandaru VV, Wang Y, Knorr D, Poirier C, Mattson MP, Geiger JD, Haughey NJ (2009). Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. J Neurochem 109:1237–1249.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.